Search Results
Mar 25, 2026, 07:49 ET PAN GLOBAL ANUNCIA UN TRAMO DE 3,0 m CON 29,8 g/t DE ORO EN PROVIDENCIA Y EL INICIO DE SONDEOS EN CÁRMENES
29,8 g/t de oro dentro de un tramo de 6,0 metros con una ley de 15,0 g/t de oro en muestreos de superficie realizados en ProvidenciaLos valores polimetálicos de alta ley incluyen 43,8 g/t de oro, 1,06 g/t de platino y 0,82 g/t de paladio
More news about: Pan Global Resources Inc.
Mar 25, 2026, 07:28 ET PAN GLOBAL REPORTS 29.8 G/T GOLD OVER 3.0 METERS AT PROVIDENCIA AND COMMENCES FOLLOW-UP DRILL PROGRAM, CÁRMENES PROJECT, SPAIN
2EU29.8 g/t gold over 3.0 meters within 6.0 meters grading 15.0 g/t gold from surface sampling at ProvidenciaHigh-grade polymetallic values include 43.8 g/t gold, 1.06 g/t platinum and 0.82 g/t palladium over 1.0 meter Follow-up
More news about: Pan Global Resources Inc.
Mar 25, 2026, 07:28 ET PAN GLOBAL REPORTS 29.8 G/T GOLD OVER 3.0 METERS AT PROVIDENCIA AND COMMENCES FOLLOW-UP DRILL PROGRAM, CÁRMENES PROJECT, SPAIN
2EU29.8 g/t gold over 3.0 meters within 6.0 meters grading 15.0 g/t gold from surface sampling at ProvidenciaHigh-grade polymetallic values include 43.8 g/t gold, 1.06 g/t platinum and 0.82 g/t palladium over 1.0 meter Follow-up
More news about: Pan Global Resources Inc.
Mar 25, 2026, 06:05 ET MGI Tech Brings High-Throughput T7+ Sequencer to European Market at Analytica 2026 Debut
platforms, including the new high-throughput sequencer T7+, now available to customers in Europe and Africa, and the automation workstation
More news about: MGI Tech Co., Ltd.
Mar 25, 2026, 04:59 ET 第十三屆微電影「創+作」支援計劃（音樂篇）頒獎典禮暨精選作品首映順利完成
最受歡迎微電影獎T. F. E.KnoowNo導演: 王卓騏
More news about: 香港互動市務商會
Mar 25, 2026, 04:00 ET Der WATO Members Club: WATO ruft die leidenschaftlichsten Liebhaber von Kostümfesten aus aller Welt zusammen
Linkhttps://www.dropbox.com/t/jvNhsrRSNnu61ORyWATO lädt zu Le Bal des Morts ein, dem extravagantesten Fest im Zeichen einer Beerdigung, das Sie je erlebt habenZehn
More news about: WATO Members Club
Mar 25, 2026, 02:53 ET Navi AI Emerges from Stealth to Accelerate Pilot Training with AI
leaders than any program in history. Working alongside TPS, Navi is tailoring its AI-driven debriefing and flight analysis capabilities for the school's T-38 fleet, an environment where precision, adaptability and rapid learning are not aspirations; they are requirements. Navi's near-term focus is
More news about: Navi AI
Mar 24, 2026, 22:40 ET Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab
R&D innovation ecosystem centered on its proprietary Tetrabody multi-specific antibody platform, Dual-Shield Antibody-Drug Conjugates (ADCs), Dual-Lock T-cell engager (TCE), Tissue-Smart siRNA, Cell Therapies, and Flex-Nano mRNA platforms. Supported by a global-standard GMP manufacturing infrastructure
More news about: Akeso, Inc.
Mar 24, 2026, 19:50 ET Clover Announces Additional Positive U.S. Phase I Clinical Data for RSV Re-Vaccination in Older Adults
levelsAREXVY homologous re-vaccination induced an approximately 40-fold increase in "off-target" antibodies against the T4-foldon trimerization tag utilized in AREXVYGiven that more than 40% of eligible adults 60 years and older in the U.S. have previously received
More news about: Clover Biopharma
Mar 24, 2026, 17:48 ET INTEGRA REPORTS FOURTH QUARTER 2025 RESULTS; STRONG ANNUAL PRODUCTION FROM FLORIDA CANYON MINE, RECORD ADJUSTED NET EARNINGS, AND STRENGTHENED FINANCIAL POSITION
groundwork for Integra's next phase of growth."Financial and Operating HighlightsUnit abbreviations in tables: kt = thousand tonnes, g/t = grams per tonne, Au = gold, oz = troy ounce, $000s = thousands of U.S. dollars, $/sh = U.S. dollars per share, $/oz = U.S. dollars per gold ounce, $/oz
More news about: Integra Resources Corp.
Mar 24, 2026, 17:15 ET ATRA Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Atara Biotherapeutics, Inc.
diseases in the U.S. and the United Kingdom ("U.K."). The Company's lead product candidate is tabelecleucel (also referred to as tab-cel or EBVALLO), a T-cell immunotherapy program for the treatment of, inter alia, Epstein-Barr virus positive post-transplant lymphoproliferative disease ("EBV+PTLD").
More news about: Robbins LLP
Mar 24, 2026, 16:21 ET /C O R R E C T I O N -- Zillow Group, Inc./
More news about: Zillow Group, Inc.
Mar 24, 2026, 16:05 ET AAR reports third quarter fiscal year 2026 results
continue to find new opportunities for growth, particularly given its government product lines. Finally, we remain on track to close our acquisition of A-R-T in the fourth quarter of fiscal year 2026."We also made solid progress with respect to our leverage. Cash from operations was $75
More news about: AAR CORP.
Mar 24, 2026, 15:39 ET Continuity Biosciences et Breakthrough T1D entrent en collaboration pour soutenir la plateforme de thérapie cellulaire NICHE® en vue d'une première étude chez l'humain
jour mener à la guérison du diabète de type 1 est une priorité essentielle pour Breakthrough T1D », déclare Asja Guzman, PhD, directrice adjointe de la recherche sur les thérapies cellulaires chez Breakthrough T1D. « La lutte contre le rejet immunitaire après une transplantation reste un défi. Nous sommes
More news about: Continuity Biosciences LLC
Mar 24, 2026, 15:28 ET ESR検査とCRP検査の併用で、病院は年間数百万ドルを節減できる可能性――新たな研究が、両検査は代替可能ではないことを示唆
、支払者の負担がわずか2.70ドルにすぎない、臨床的に価値のある検査を維持することは理にかなっています。研究について引用元：Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. "Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests.". ClinicoEconomics and Outcomes
More news about: Alcor Scientific
Mar 24, 2026, 15:24 ET TAYLOR FARMS ACQUIRES EQUINOX GROWERS, LARGEST GREENHOUSE IN MID-ATLANTIC
throughout the Eastern U.S."Retailers and consumers alike are increasingly seeking long-term, reliable access to greenhouse grown produce," said T. Bruce Taylor, Senior Vice President of Marketing and Product. "We're taking a major step forward into controlled-environment agriculture as this
More news about: Taylor Farms
Mar 24, 2026, 15:24 ET Memesan Tes Laboratorium ESR dan CRP Sekaligus Dapat Menghemat Jutaan Dolar Setiap Tahun Bagi Rumah Sakit -- Penelitian Baru Ini Menentang Anggapan Bahwa Keduanya Dapat Saling Menggantikan
mencegah tes lanjutan yang tidak perlu.Tentang Penelitian IniKutipan: Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. "Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests." ClinicoEconomics and Outcomes
More news about: Alcor Scientific
Mar 24, 2026, 15:16 ET /C O R R E C T I O N -- Forward Advantage/
More news about: Forward Advantage
Mar 24, 2026, 15:15 ET Continuity BiosciencesとBreakthrough T1D、NICHE®細胞療法プラットフォームのヒト初回臨床試験に向けて協業
この取り組みは、Breakthrough T1DのIndustry Discovery and Development Partnership（IDDP）プログラムを通じて支援されています。このプログラムは、T1Dの治療、治癒、予防に向けた有望な治療プログラムの加速を目的とする研究プロジェクトに資金を提供するものです。成功すれば、NICHEプラットフォームは、全身免疫抑制を最小限に抑えつつ、細胞移植片の直接的な血管化と局所的な免疫保護を可能にすることで、T1Dにおける細胞ベース治療の新たな送達パラダイムとなる可能性があります。この提携により、埋め込み型の精密制御薬物送達システムに関するContinuityの専門性と、T1Dエコシステム全体のイノベーションを加速するBreakthrough
More news about: Continuity Biosciences LLC
Mar 24, 2026, 14:57 ET Continuity Biosciences 與 Breakthrough T1D 攜手推進 NICHE® 細胞治療平台邁向首次人體臨床研究
Breakthrough T1D 的行業探索與開發合作夥伴關係 (Industry Discovery and Development Partnership, IDDP) 計劃支持，該計劃旨在資助研究項目，加快推進具潛力的治療方案，以促進一型糖尿病的治療、治癒及預防。若項目成功，NICHE 平台有望為一型糖尿病的細胞療法帶來嶄新的遞送模式，透過實現細胞直接血管生成及局部免疫保護，同時將全身免疫抑制的需求降至最低。是次合作結合了 Continuity 在可植入式、精準控制藥物遞送系統方面的專業技術，以及 Breakthrough T1D 在推動一型糖尿病 (T1D) 生態系統創新方面的全球領導地位。
More news about: Continuity Biosciences LLC
Mar 24, 2026, 14:46 ET UCB Selects Georgia for New U.S. Biologics Manufacturing Facility; ~$5B Economic Impact and ~330 Permanent Jobs
contact UCB:Investor Relations Antje Witte T +32.2.559.94.14 email [email protected] Yazdian T +32.2.559.91.37 email
More news about: UCB